P

Inventor

SANTANGELO FRANCESCO

IT45 patents
⚠️ This page may combine multiple inventors who share the name “SANTANGELO FRANCESCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZAMBON SPA

30 patents
US5196440AMar 23, 1993

Compounds active as inhibitors of the cholesterol biosynthesis

ZAMBON SPA68 citations96
US4940800AJul 10, 1990

Beazimidazole compounds active as inhibitors of the cholesterol biosynthesis

ZAMBON SPA67 citations96
US5739123AApr 14, 1998

Phosphinic acid derivatives with metallopeptidase inhibitory activity

ZAMBON SPA50 citations92
US5468746ANov 21, 1995

Compounds active on the cardiovascular system

ZAMBON SPA36 citations92
US5081136AJan 14, 1992

1,2,3-triazole compounds active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them

ZAMBON SPA62 citations92
US5747513AMay 5, 1998

Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system

ZAMBON SPA22 citations91
US6589951B1Jul 8, 2003

Phthalazine derivatives as phosphodiesterase 4 inhibitors

ZAMBON SPA19 citations79
US4983606AJan 8, 1991

Pharmaceutically-active phthalazine compounds

ZAMBON SPA10 citations74
US5426179AJun 20, 1995

Steroid compounds active on the cardiovascular system

ZAMBON SPA7 citations73
US5407956AApr 18, 1995

2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them

ZAMBON SPA7 citations72
US5519054AMay 21, 1996

Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract

ZAMBON SPA8 citations71
US6107318AAug 22, 2000

Naphthothiazolone derivatives active on the D3 dopaminergic receptor

ZAMBON SPA9 citations67
US6627659B1Sep 30, 2003

Methods of decreasing the effects of oxidative stress using N-acetylcysteine

ZAMBON SPA4 citations63
US5506259AApr 9, 1996

β-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases

ZAMBON SPA2 citations63
US5438046AAug 1, 1995

N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases

ZAMBON SPA4 citations63
US5438047AAug 1, 1995

Diphosphates of catecholamines and pharmaceutical compositions containing them

ZAMBON SPA6 citations63
US5221770AJun 22, 1993

Process for the preparation of 2-amino-5,6-dimethoxy-tetralin

ZAMBON SPA4 citations63
US6548480B1Apr 15, 2003

Phosphonic acid derivatives with metallopeptidase inhibitory activity

ZAMBON SPA3 citations62
US6211380B1Apr 3, 2001

Process for the preparation of heteroaryl-zinc halides

ZAMBON SPA4 citations62
US6166051ADec 26, 2000

Thiol derivatives with metallopeptidase (ACE/NEP) inhibitory activity

ZAMBON SPA2 citations62
US5866604AFeb 2, 1999

Thiol derivatives with metallopeptidase inhibitory activity

ZAMBON SPA6 citations62
US5760241AJun 2, 1998

Thiol derivatives with metallopeptidase inhibitory activity

ZAMBON SPA3 citations62
US6080768AJun 27, 2000

Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system

ZAMBON SPA2 citations61
US5451608ASep 19, 1995

2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them

ZAMBON SPA5 citations61
US5760285AJun 2, 1998

Phosphonyldipeptides useful in the treatment of cardiovascular diseases

ZAMBON SPA1 citations52
US5994539ANov 30, 1999

Mercapto acyl aminoacid derivatives endowed with dual ACE-NEP inhibitory activity, useful in the treatment of cardiovascular diseases

ZAMBON SPA0 citations51
US5716943AFeb 10, 1998

Phosphinic acid derivatives with metallopeptidase inhibitory activity

ZAMBON SPA1 citations51
US6063964AMay 16, 2000

5-hydroxymethyl-2-aminotetralins as cardiovascular agents

ZAMBON SPA0 citations50
US5847092ADec 8, 1998

Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity

ZAMBON SPA0 citations50
US6232348B1May 15, 2001

Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent

ZAMBON SPA0 citations36

SIMES

10 patents

ERBA FARMITALIA

2 patents

ZAMBON GROUP

1 patent

(unassigned)

1 patent

BIO 3 RES S R L

1 patent